Genscript Biotech

ISIN KYG3825B1059

WKN A2ACSB

Market cap (in EUR)

3,387 m

Country

China

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Show more Show less

Healthcare Healthcare Services Miscellaneous Healthcare China

Financials

Key metrics

Market capitalisation, EUR	3,387 m
EPS, EUR	-
P/B ratio	0.9
P/E ratio	0.9
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	554 m
Net income, EUR	-62 m
Profit margin	-11.21%

What ETF is Genscript Biotech in?

There are 23 ETFs which contain Genscript Biotech. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genscript Biotech is the iShares MSCI Emerging Markets Islamic UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares MSCI AC Far East ex-Japan UCITS ETF	0.03%	Equity Asia Pacific	949
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating	0.00%	Equity World Multi-Asset Strategy	896
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing	0.00%	Equity World Multi-Asset Strategy	14
iShares MSCI ACWI UCITS ETF USD (Acc)	0.00%	Equity World	22,108
iShares MSCI EM UCITS ETF (Dist)	0.02%	Equity Emerging Markets	6,592
UBS Core MSCI EM UCITS ETF USD dis	0.02%	Equity Emerging Markets	2,024
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing	0.00%	Equity World Multi-Asset Strategy	67
Amundi MSCI Disruptive Technology UCITS ETF Acc	0.05%	Equity World Technology Social/Environmental Innovation	143
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating	0.00%	Equity World Multi-Asset Strategy	193
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating	0.00%	Equity World Multi-Asset Strategy	683
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	Equity World Social/Environmental	497
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing	0.03%	Equity Emerging Markets Social/Environmental	15
iShares MSCI EM IMI Screened UCITS ETF USD (Dist)	0.02%	Equity Emerging Markets Social/Environmental	1,179
iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist)	0.05%	Equity Emerging Markets Social/Environmental	937
Vanguard FTSE All-World UCITS ETF (USD) Accumulating	0.00%	Equity World	27,971
Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating	0.02%	Equity Emerging Markets	1,428
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist	0.03%	Equity Emerging Markets	843
Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing	0.02%	Equity Emerging Markets	2,759
iShares MSCI Emerging Markets Islamic UCITS ETF	0.07%	Equity Emerging Markets Islamic Investing	332
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing	0.00%	Equity World Multi-Asset Strategy	34
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing	0.00%	Equity World Multi-Asset Strategy	89
Vanguard FTSE All-World UCITS ETF (USD) Distributing	0.00%	Equity World	19,168
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating	0.00%	Equity World Multi-Asset Strategy	87

Change your settings